Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.

World journal of gastroenterology - 28 Nov 2014

Bernabucci Veronica, Ciancio Alessia, Petta Salvatore, Karampatou Aimilia, Turco Laura, Strona Silvia, Critelli Rosina, Todesca Paola, Cerami Caterina, Sagnelli Caterina, Rizzetto Mario, Cammà Calogero, Villa Erica

Abstract excerpt

AIM: To investigate the safety/efficacy of Boceprevir-based triple therapy in hepatitis C virus (HCV)-G1 menopausal women who were historic relapsers, partial-responders and null-responders. METHODS: In this single-assignment, unblinded study, we treated fifty-six menopausal women with HCV-G1, 46% F3-F4, and previous PEG-α/RBV failure (7% null, 41% non-responder, and 52% relapser) with 4 wk lead-in with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Menopause

Share to Polyethylene Glycols

Share to Proline

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 25469044
DOI: 10.3748/wjg.v20.i44.16726
PMCID: PMC4248219

Genes

BOC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.PMID 25469044Read ↗

Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.Semantic proximity Read ↗

Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis.Semantic proximity Read ↗

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response.Semantic proximity Read ↗

Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapy.Semantic proximity Read ↗

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.Semantic proximity Read ↗

Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin.Semantic proximity Read ↗

Effect of Gender on the Response to Hepatitis C Treatment in an Inner-City Population.Semantic proximity Read ↗

Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin.Semantic proximity Read ↗

Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.